Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $10.33
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 16, 26 |
Daily · Wilder smoothing
| Keybanc |
| maintain |
| Overweight |
| Overweight |
| Oct 13, 26 | TD Cowen | maintain | Buy | Buy |
| Oct 7, 26 | Barclays | maintain | Equal Weight | Equal Weight |
| Sep 30, 26 | UBS | downgrade | Buy | Neutral |
| Aug 5, 26 | Barclays | maintain | Equal Weight | Equal Weight |
| May 12, 26 | Stephens & Co. | maintain | Overweight | Overweight |
| May 12, 26 | BMO Capital | maintain | Market Perform | Market Perform |
| May 12, 26 | Barclays | maintain | Equal Weight | Equal Weight |
| May 12, 26 | Craig-Hallum | maintain | Hold | Hold |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 65.29 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 92.87 | Oscillator | Sell |
| Williams %R (14) | -2.23 | Oscillator | Sell |
| MACD (12, 26, 9) | 0.39 (Hist 0.06) | Oscillator | Strong Buy |
| Average Directional Index (14) | 42.93 (+DI 33.0 / -DI 7.1) | Trend | Strong Buy |
| EMA 20 | 9.47 | MA | Strong Buy |
| SMA 20 | 9.47 | MA | Strong Buy |
| EMA 50 | 8.81 | MA | Strong Buy |
| SMA 50 | 8.73 | MA | Strong Buy |
| SMA 200 | 7.23 | MA | Strong Buy |
TTM vs. 5-year historical average (annual ratios)
| Metric | CERT | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -23.3x | -244.6x · sector 20.7x | Discount |
| Forward P/E (FY26E) | 30.4x | EPS est. 0.34 | Discount |
| Price / Book | 1.6x | 2.4x | Discount |
| Price / Sales | 3.9x | 7.6x | Discount |
| EV / EBITDA | 16.5x | 52.3x | Discount |
| Return on equity | -6.7% | — | Weak |
| Gross margin | 58.3% | 60.6% | In line |
| Debt / Equity | 0.30 | 0.24 | Conservative |
| Piotroski / Altman Z | 7/9 | Z 2.51 | Grey zone |
Discounted cash flow model
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Sep 2, 2026 | 2026-09-02 16:57:52 | View |
| 8-K | Aug 7, 2026 | 2026-08-07 16:20:22 | View |
| 10-Q | Aug 4, 2026 | 2026-08-04 07:19:08 | View |
| 8-K | Aug 4, 2026 | 2026-08-04 07:09:53 | View |
| 8-K | Aug 4, 2026 | 2026-08-04 07:00:38 | View |
| 3 | Jul 17, 2026 | 2026-07-17 16:50:25 | View |
| SC 13G/A | Jul 14, 2026 | 2026-07-14 13:27:06 | View |
| SC 13G/A | Jul 8, 2026 | 2026-07-08 11:12:31 | View |
| 8-K | Jun 17, 2026 | 2026-06-17 16:30:24 | View |
| 4 | Jun 2, 2026 | 2026-06-02 17:15:27 | View |
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
Certara (NASDAQ: CERT - Get Free Report) and Weave Communications (NYSE: WEAV - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk. Risk and Volatility Certara has a beta of
Certara (NASDAQ: CERT - Get Free Report) and Doximity (NYSE: DOCS - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability. Analyst Recommendations This is a breakdown of current recommendations for
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | 0.09 | 0.08 | Miss -10.4% | $93.27M |
| May 11, 2026 | 0.11 | 0.09 | Miss -18.2% | $106.9M |
| Feb 26, 2026 | 0.11 | 0.09 | Miss -18.2% | $103.6M |
| Nov 6, 2025 | 0.11 | 0.14 | Beat 27.3% | $104.6M |
| Aug 6, 2025 | 0.10 | 0.07 | Miss -30.0% | $104.6M |
| May 5, 2025 | 0.13 | 0.14 | Beat 7.7% | $106.0M |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 1, 26 | Mohammed Faiz | officer: Interim CFO | A-Award | 63,532 | — |
| Jul 15, 26 | Mohammed Faiz | officer: Interim CFO | 0 | — | |
| Jul 15, 26 | Mohammed Faiz | officer: Interim CFO | 13,290 | — | |
| Jul 15, 26 | Mohammed Faiz | officer: Interim CFO | 8,544 | — | |
| Jun 1, 26 | Anhalt Rona | officer: Chief Human Resources Officer | M-Exempt | 7,147 | — |
| Jun 1, 26 | Anhalt Rona | officer: Chief Human Resources Officer | F-InKind | 2,241 @ $5.82 | $13.04K |
| Jun 1, 26 | Anhalt Rona | officer: Chief Human Resources Officer | M-Exempt | 7,147 | — |
| Jun 1, 26 | Corcoran Daniel | officer: SVP and General Counsel | M-Exempt | 14,889 | — |